Dr Mike Trower CSO KaNDy Therapeutics will present at the 9th International Congress of Neuroendocrinology, Toronto, Canada July 15th – 18th, 2018

Mary Kerr CEO NeRRe Therapeutics and Managing Director KaNDY Therapeutics will be presenting a case study on the “Demerger of NT-814 to KaNDY Therapeutics, Business Model Innovation and Value Creation; 7TH LSX CEO FORUM , Wednesday 27th June 2018, CMS, Cannon Place, 78 Cannon St, London EC4N 6AF

KaNDy Therapeutics and NeRRe Therapeutics announce the appointment of Jo Craig as Head of Chemistry Manufacturing and Controls

Stevenage, UK, 21 June 2018 – KaNDy Therapeutics, a UK clinical-stage biotech company, today announces the appointment of Jo Craig as Head of Chemistry Manufacturing and Controls for both KaNDy [...]

KaNDy Therapeutics Managing Director to present at The Anglonordic Life Science Conference

24th May 2018: KaNDy Therapeutics Managing Director, Dr Mary Kerr, is invited to present at The Anglonordic Life Science Conference 11:00am -12.30pm in the Biotech Investment Room, County Hall, [...]

Dr Mary Kerr presents at the Biotech Showcase, San Francisco

9th January 2018: KaNDy Therapeutics Managing Director, Dr Mary Kerr, presents at the Biotech Showcase, 14:30 Franciscan – C (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA

Mary Kerr MD KaNDy Therapeutics guest speaker at a recent Labiotech meeting in London

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt